Literature DB >> 21358602

Confirmation of HIV-like sequences in respiratory tract bacteria of Cambodian and Kenyan HIV-positive pediatric patients.

Vladimir Zajac1, Lenka Matelova, Anna Liskova, Michal Mego, Vladimir Holec, Zuzana Adamcikova, Viola Stevurkova, Andrea Shahum, Vladimir Krcmery.   

Abstract

BACKGROUND: Bacteria and yeasts isolated from respiratory tracts of 39 Cambodian and 28 Kenyan HIV-positive children were tested for the presence of HIV-1 sequences. MATERIAL/
METHODS: Bacteria and yeasts from the respiratory tract (nose, pharyngeal swabs) were isolated from 39 Cambodian and 28 Kenyan HIV-positive children. Bacterial chromosomal DNA was prepared by standard protocol and by Qiagen kit. The PCR specific for HIV sequences was carried out using HIV-1-specific primers.The analysis was performed by colony and dot-blot hybridization using HIV-1-specific primers which represent gag, pol and env genes of the virus. The sequencing of some PCR products was performed on the ABI 373 DNA Sequencer.
RESULTS: The majority of microbes were characterized as Staphylococcus aureus, Klebsiella pneumoniae, and resp. Candida albicans. In some cases E. coli, Streptococcus pyogenes, Proteus mirabilis and Candida tropicalis were identified. Bacteria of 16 Cambodian (41%) and 8 Kenyan (31%) children were found to be positive in colony and dot-blot DNA hybridization. By the sequencing of PCR products synthesized on the template of patients' bacterial DNA using primers 68;69 for env HIV-1 gene, homology of greater than 90% with HIV-1 isolate HXB2 (HIVHXB2CG) was revealed.
CONCLUSIONS: Bacteria and yeasts from the respiratory tract of 41% of Cambodian and 31% of Kenyan HIV-positive children bear HIV-like sequences. The role of bacteria in the HIV disease process is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21358602      PMCID: PMC3524724          DOI: 10.12659/msm.881449

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

It has recently been found that both acute human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are accompanied by a dramatic and selective loss of memory CD4+ T cells, predominantly from the mucosal surfaces [1]. Gut-associated lymphatic tissue (GALT), the largest component of the lymphoid organ system, is a principal site of both virus production and depletion of primarily lamina propria memory CD4+ T cells. CD4-expressing T cells that previously encountered antigens and microbes are homed to the lamina propria of GALT [2]. The scale of this CD4+ T-cell depletion has adverse effects on the immune system of the host, emphasizing the significance of developing countermeasures to SIV that are effective before infection of GALT. The SIV directly killed a massive number of immune cells in the gut within days of infection. The gut-associated lymphoid tissue (GALT) is an important early site for HIV replication and severe CD4+ T cell depletion [3]. Viral suppression and immune restoration exists in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection [3]. In individuals treated with highly active anti-retroviral therapy (HAART), the plasma HIV RNA is reduced to below the level of detection, but there is strong evidence of continuing viral replication after suppression of plasma viremia. It is apparent that a viral reservoir persists in virtually all infected individuals receiving HAART [4,5]. As shown previously, HIV-1 was also detected in bowel crypt cells and the lamina propria in HIV-positive patients [6]. Since these cells are in close contact with intestinal bacteria, it may be possible that bowel bacteria are involved in the pathogenesis of the disease. These findings, confirming that the gut and other mucosal tissue, rather than blood, is the major site of HIV infection and CD4+T cell loss, suggest the possibility that bacteria might serve as a viral reservoir as well. Based on our previous results concerning detection of HIV-1 sequences in gastrointestinal tracts of HIV-positive patients [7-9], we analysed bacteria and yeasts isolated from the respiratory tract (nose, pharyngeal swabs) of Cambodian and Kenyan HIV-positive children for presence of HIV-like sequences. The study protocol was reviewed and approved by the Ethics Committee of St. Elizabeth University.

Material and Methods

DNA isolation and PCR amplification

Bacteria and yeasts from the respiratory tract (nose, pharyngeal swabs) were collected from 39 Cambodian and 28 Kenyan HIV-positive children. Collected samples were directly transported from Cambodia and Kenya to the Cancer Research Institute in Bratislava and incubated overnight in LB medium at 37°C for amplification. Bacterial chromosomal DNA was prepared by standard protocol [10,11] and by Qiagen kit (Qiagen). Plasmid DNA was purified by an alkaline lysis procedure (Table 1).
Table 1

The PCR specific for HIV sequences was carried out using the following primers.

GenePrimerSequences 5′-3′Product size (bp)Position
gag38forATAATCCACCTATCCCAGTAGGAGAAT1151075
39revTTTGGTCCTTGTCTTATGTCCAGAATG1162
polPforCATTTGGAAAGGACCAGCAAAACTACT14844457
ErevTCATATGCTTTAGCATCTGATGCACAA5914
env68forAGCAGCAGGAAGCACTATGG1427302
69revCCAGACTGTGAGTTGCAACAG7423
To avoid false positive results, 3 PCR reactions were performed as arbitrary controls in every set of reactions. The PCR products, used for sequencing and for HIV-specific probe, were purified through LMP agarose and by QIAquick PCR purification kit (Qiagen). Plasmid pBH10 (genebank accession number M15654) was used as a reference source of HIV DNA and lymphocytes’ DNA of HIV/AIDS patient 30 was used as a template for PCR products.

Dot-blot hybridization

For dot-blotting, bacteria and yeasts isolated from patients were amplified overnight in LB medium, and chromosomal DNA was prepared. DNA (0.25 μg/sample) of each patient was transferred to Hybond N+ membrane, lysed and prehybridized. For probe, the 3 aforementioned purified PCR products were synthesized on DNA template: a) HIV/AIDS patient 30; b) plasmid pBH10. 32P-labelled probe was obtained by Ready-To-Go DNA Labelling Kit (Amersham Bioscience, England). Hybridization was performed for 16 hours in standard hybridization buffer at 42°C or in Rapid-hyb buffer (Amersham Bioscience) at 60°C, and washing was carried out as described previously [9]. To exclude potential contamination, 8 DNA samples of healthy persons were analysed together with tested children.

Southern hybridization

For colony blotting, bacterial suspension was diluted to the concentration of 10−10 or 10−9 on LB plates and grown colonies were blotted to the Hybond N+ membrane, lysed, washed and prehybridized. 32P-labeled probes were obtained using Ready-To-Go DNA Labeling kit (−dCTP) (Amersham Bioscience). The combined PCR probe was prepared as a mixture of all 3 aforementioned PCR products. Hybridization was performed for 16 hours in standard hybridization buffer at 42°C or in Rapid-hyb buffer (Amersham Bioscience) at 60°C. Subsequently, membranes were washed at final temperature 60°C, resp. 65°C.

DNA sequencing

The PCR products determined by primers 68, 69 synthesized on the template of bacterial DNA were directly sequenced on the ABI 373 DNA Sequencer and ABI PRISM 310 Genetic Analyzer (Applied Biosystem). The sequencing reaction was performed using fluorescent dyes of the ABI Prism Big Dye Terminator sequencing kit (Applied Biosystems) and afterwards extension products were purified by Auto-Seq G-50 columns (Amersham Biosciences).

Results

The bacteria and yeast isolates from the respiratory tract of Cambodian and Kenyan HIV-positive children were Staphylococcus aureus, Streptococcus pyogenes, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Candida albicans and Candida tropicalis (Table 2). There were no evident differences between the proportions of species from children of both countries; however, differences were detected in dot-blot hybridization with HIV-1 probes (Figures 1, 2). DNA isolated from 39 tested Cambodian children hybridized for 41% (16 samples) with used probes and for 29% (8 samples) from 28 tested Kenyan children. The most frequently found bacteria in both Cambodian [12] and Kenyan [6] children was Klebsiella pneumoniae. This bacteria was positive in hybridization for 50% and 67% (Table 2). Candida albicans of 7 Kenyan patients was completely negative in colony and dot-blot hybridization, but was positive in 3 out of 5 Cambodian children. Escherichia coli detected in 3 Cambodian children hybridized positively in 2 cases. Candida tropicalis was found in 1 patient from Kenya and hybridized with HIV-1 probes. Proteus mirabilis of 1 Cambodian child was found positive in hybridization with used probes.
Table 2

Distribution of bacteria isolated from Cambodian (A)/Kenyan (B) HIV positive children and summary of hybridization results with HIV-1 specific probes.

A. 39 Cambodian HIV positive children.
Bacterial strainNumberPositive hybridization
Klebsiella pneumoniae12 (31.0%)6 (50.0%)
Candida albicans5 (13.0%)3 (60.0%)
Staphylococcus aureus15 (38.5%)2 (13.5%)
(MRSA)2 (5.0%)1 (50.0%)
Streptococcus pyogenes3 (8.0%)2 (67.0%)
Escherichia coli1 (2.5%)1 (100.0%)
Proteus mirabilis1 (2.5%)1 (100.0%)
3916 (41.0%)
Figure 1

Dot-blot hybridization of bacterial DNA (0.25 μg) from Cambodian HIV positive children. The hybridization probe was mixture of purified PCR products that represented gag, pol and env HIV-1 genes synthesized on the template of plasmid pHB10. Samples of 39 patients were applied in lines from A to G. The control samples of 8 healthy persons are located in lines H and I. In the last line J in position 6 is DNA of tested child with shining clinically expression of disease and in positions 2, 3 are mixtures of aforementioned PCR products in dilution 1:100 and 1:50.

Figure 2

Dot-blot hybridization of bacterial DNA (0.25 μg) from Kenyan HIV positive children. The hybridization probe was mixture of purified PCR products represented gag, pol and env HIV-1 genes synthesized on template of patient 30. Samples of 28 patients were applied in lines from A to E. The control samples of 8 healthy persons are located in lines F and G. In the last line H in position 4 is DNA of the child with shining clinically expression of disease and in positions 5, 6 are mixtures of aforementioned PCR products in dilution 1:100 and 1:50.

The results of colony (data not shown) and dot-blot hybridization were highly compatible. The differences in hybridization using probes of PCR products synthesized on 2 different templates – pBH10 and DNA of patient 30 – were not significant. The 142 bp amplicon limited by primers 68; 69 produced using template DNA from both bacteria and lymphocytes of Kenyan (9 Ke, 22 Ke, 10’ Ke, 30 Ke, 5’ Ke, 16’ Ke, 29 Ke) and Cambodian children (15 Cm, 28 Cm, 33 Cm) was sequenced (Figure 3). Amplicons from these different sources were more than 90% identical with reference sequences (HIV/HXB2). Some differences were found in the first part of sequenced fragments. Largest differences were detected between the isolates as a group and the reference sequence in pBH10.
Figure 3

Comparison of the sequences of 142 bp PCR products synthesized on the template of Kenyan (Ke) and Cambodian (Cm) patient bacterial DNA, determined by primers 68;69, of patients: 9 Ke, 22 Ke, 30 Ke, 5’ Ke, 10’ Ke, 16’ Ke, 29’ Ke, 15 Cm, Cm.28, 33 Cm. As a reference sequences was used HIV-1 isolate HIV/HXB2.

Discussion

Recent observations suggest that the main fight against the HIV disease process is performed in gut-associated lymphatic tissue closed to the gastrointestinal tract [1-3,11]. Our understanding about the restoration of the gut mucosal immune system during highly active antiretroviral therapy is very limited. A dramatic loss of CD4+T cells, predominantly from the mucosal surfaces, suggests the question of whether bacteria play some role in this process. Our previous detection of HIV-like sequences in gut bacteria of HIV/AIDS patients may confirm that bacteria are involved in this trial [7,12,13]. Accordingly, in the respiratory tract bacteria of HIV-positive children from Cambodia and Kenya, HIV-like sequences were detected in 41% and 29%, respectively, of samples. Klebsiella pneumoniae, detected most frequently in both cohorts, hybridized with HIV-1-specific probes in 50% and 67%, respectively. These results were expected, because Klebsiella is a gut commensal localized in the intestinal tract, where previously detected bacteria bearing HIV-like sequences were found [12]. The second most isolated Staphylococcus aureus, colonizing mostly skin and/or respiratory tract, hybridized only 13.5% and 10%, respectively, with HIV-1-specific probes. Candida tropicalis was detected once, with a positive hybridization signal. On the basis of our previous detection of HIV-like sequences in bacteria isolated from the respiratory tract of AIDS patients [7], it is possible to conclude that bacteria bearing HIV-like sequences are localized not only in the intestinal tract of HIV/AIDS patients, but in other organs as well [12,13]. The transmission of these organisms and their role in AIDS pathogenesis is not clear. Some bacteria probably may serve as a reservoir of HIV-like sequences in the form of “virus-like HIV particles” or as HIV. Our sequencing results showed a very high homology (over 90%) between bacterial HIV-like sequences and HIV-1 isolate HXB2 (HIVHXB2CG). Because all the above mentioned species are gut or skin commensals that cannot be eliminated, they may represent continual imminency for the host. On the other hand, differences in homology of patient’s env sequences limited by primers 68;69 with coresponding pBH10 sequences, eliminated to a large extent suspicion of contamination. HIV-1 sequences presented in pBH10 are only one source of retroviral genetic information in laboratory. There is increasing evidence that the mucosa-associated bacteria may play important roles in the pathogenesis of inflammatory bowel disease, ulcerative colitis, Crohn’s disease and potentially even colon cancer [14,15]. Invasive strains of E. coli that undergo lyses upon entry into mammalian cells can act as a stable DNA delivery system to their hosts [16]. They work on the basis of “hit and run away”, and their extrachromosomal content remains mainly in the host cell, even when the bacterial carriers are not detectable. Horizontal gene transfer from bacteria to yeast, to plant and mammalian cells has been reported by other investigators [16-19].

Conclusions

Bacteria and yeasts from the respiratory tract of 41% of Cambodian and 31% of Kenyan HIV-positive children bear HIV-like sequences. According to our preliminary results, we conclude that the ability of invasive bacteria containing HIV sequences in the form of “virus-like particles” to enter into HL-60 cells or human lymphocytes represents an ideal system for of horizontal transfer of genes between eukaryotic and prokaryotic cells. In this way “virus-like particles” or other particles are introduced into cells of the lymphoproliferative system, and, consequently, their genetic information may interact with or be integrated into the human DNA and induce the HIV disease process [7,8].
  16 in total

1.  Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Authors:  T W Chun; R T Davey; M Ostrowski; J Shawn Justement; D Engel; J I Mullins; A S Fauci
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Conjugation between bacterial and mammalian cells.

Authors:  V L Waters
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

3.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

4.  Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer.

Authors:  Helen M Martin; Barry J Campbell; C Anthony Hart; Chiedzo Mpofu; Manu Nayar; Ravinder Singh; Hans Englyst; Helen F Williams; Jonathan M Rhodes
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

5.  HIV swiftly guts the immune system.

Authors:  Ronald S Veazey; Andrew A Lackner
Journal:  Nat Med       Date:  2005-05       Impact factor: 53.440

6.  Detection of HIV-1 sequences in intestinal bacteria of HIV/AIDS patients.

Authors:  Vladimir Zajac; Viola Stevurkova; Lenka Matelova; Eduard Ujhazy
Journal:  Neuro Endocrinol Lett       Date:  2007-10       Impact factor: 0.765

7.  Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.

Authors:  Moraima Guadalupe; Sumathi Sankaran; Michael D George; Elizabeth Reay; David Verhoeven; Barbara L Shacklett; Jason Flamm; Jacob Wegelin; Thomas Prindiville; Satya Dandekar
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

8.  Functional gene transfer from intracellular bacteria to mammalian cells.

Authors:  C Grillot-Courvalin; S Goussard; F Huetz; D M Ojcius; P Courvalin
Journal:  Nat Biotechnol       Date:  1998-09       Impact factor: 54.908

9.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

10.  Testing of bacteria isolated from HIV/AIDS patients in experimental models.

Authors:  Vladimír Zajac; Michal Mego; David Martinický; Viola Stevurková; Sona Cierniková; Eduard Ujházy; Andrej Gajdosík; Alena Gajdosíková
Journal:  Neuro Endocrinol Lett       Date:  2006-12       Impact factor: 0.765

View more
  3 in total

1.  Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?

Authors:  Carlo Brogna; Barbara Brogna; Domenico Rocco Bisaccia; Francesco Lauritano; Giuliano Marino; Luigi Montano; Simone Cristoni; Marina Prisco; Marina Piscopo
Journal:  Vaccines (Basel)       Date:  2022-04-29

2.  Analysis of bacteria from intestinal tract of FAP patients for the presence of APC-like sequences.

Authors:  Vladimir Holec; Sona Ciernikova; Lenka Wachsmannova; Zuzana Adamcikova; Katarina Hainova; Michal Mego; Viola Stevurkova; Ludovit Danihel; Anna Liskova; Vladimir Zajac
Journal:  Med Sci Monit       Date:  2012-08

Review 3.  Evolutionary view of the AIDS process.

Authors:  Vladimir Zajac
Journal:  J Int Med Res       Date:  2018-08-08       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.